US Edition
HPV Cancer Burden by Anatomical Site, Country, and Region in 2022
4 Articles
4 Articles
HPV cancer burden by anatomical site, country, and region in 2022
HPV vaccination can prevent more than 90% of HPV infection-related cancers. Understanding the epidemiological burden of HPV-related cancers can better promote HPV vaccination and HPV-based screening programs. We used three databases—Global Burden of Disease 2021 (GBD2021), Global Cancer Observatory 2022 (GLOBOCAN2022), and Cancer Incidence in Five Continents Plus (CI5Plus)—to evaluate the global disease burden of cervical cancer, penile cancer, …
Rising SCAC Incidence and Evolving First-Line Standards
A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human papillomavirus vaccination (which may reduce cancer rates in 10-20 years), while acknowledging significant unmet therapeutic needs including personalized approaches for high-risk locoregional disease with 40% recurrence rates and improved treatments for metastatic disease where median survival remains under 20 months, leading to the r…
"I don't remember getting much information about what it was for. It may be that someone mentioned that it was for cervical cancer. Thus begins the story of a young woman who does not want to be named, but whom Kringvarpið teaches. She is one of those who did not get vaccinated when she was offered it as a teenager. A few years later, she was diagnosed with HPV and cervical cancer, which then meant that she had to undergo surgery. She is sti…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
To view factuality data please Upgrade to Premium
